Vietnam is accelerating plans to develop its biotechnology sector as the global market grows over 13 percent annually and is projected to reach nearly US$3.88 trillion by 2030, with scientists and policymakers calling for stronger investment, commercialization, and international-standard ecosystems, the Tuoi Tre newspaper reported.

The outlook was presented at a national scientific conference on Vietnam’s biotechnology development strategy for the 2026-30 period, with a vision to 2045.

The event was jointly hosted by Vietnam National University-Ho Chi Minh City; the Party Central Committee’s Commission for Information, Education, and Mass Mobilization; and the Ministry of Science and Technology, in Ho Chi Minh City on Nov. 29.

Nguyen Phu Hung, head of the Department of Technical Science and Technology under the Ministry of Science and Technology, said biotechnology is entering a strategic phase and has become one of the most important drivers of future economic growth.

He noted that Vietnam has already mastered several core technologies, including CRISPR/Cas9 gene editing, cell technology, recombinant DNA, and next-generation vaccine technologies, which are gradually being applied to production.

As of September this year, Vietnam had approved 217 science and technology missions in the biotechnology sector, with total funding exceeding VND754 billion (US$29 million).

According to Tuoi Tre, in agriculture, biotechnology applications have delivered some of the most visible breakthroughs. More than 180 rice varieties and 53 medicinal plant species have now been DNA-barcoded.

Biotechnology-based production models have helped raise economic efficiency by 15-20........

© Eurasia Review